Come As You Are - Assessing the Efficacy of a Nurse Case Management HIV Prevention and Care Intervention Among Homeless Youth

June 6, 2025 updated by: Diane Santa Maria, The University of Texas Health Science Center, Houston
The purpose of this study is to to determine the efficacy of the Nurse Case Management HIV (NCM4HIV) intervention on HIV prevention compared to usual care among Youth Experiencing Homelessness (YEH).

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

474

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • The University of Texas Health Science Center at Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • youth engaged in high-risk sexual activity or intravenous drug use
  • speak English
  • homeless
  • not planning to move out of the metro area during the study

Exclusion Criteria:

  • youth with very low literacy
  • severe acute mental symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NCM4HIV
Participant will receive NCM4HIV intervention which includes Personalized HIV prevention education, behavior goal-setting,behavioral self-monitoring,Pre exposure prophylaxis (PrEP) eligibility screening,PrEP/non occupational post exposure prophylaxis(nPEP)services (labs, medication), healthcare planning/coordination, Motivational Interviewing (MI) counseling approach, assisting with cognitive appraisals (clarifying misconceptions),promoting health seeking and coping behaviors that incorporate the situational, personal, social, and resource needs affecting health
Participant will receive NCM4HIV intervention which includes Personalized HIV prevention education, behavior goal-setting,behavioral self-monitoring, PrEP eligibility screening,PrEP/nPEP services (labs, medication), healthcare planning/coordination, MI counseling approach, assisting with cognitive appraisals (clarifying misconceptions),promoting health seeking and coping behaviors that incorporate the situational, personal, social, and resource needs affecting health
Placebo Comparator: Usual care
Participants will receive the usual care which includes Housing, food, and clothing needs,health assessment, basic healthcare, limited anticipatory guidance, mental health counseling,substance use treatment referrals,PrEP/nPEP referrals
Participant will receive usual care which includes Housing, food, and clothing needs,health assessment, basic healthcare, limited anticipatory guidance, mental health counseling, substance use treatment referrals, PrEP/nPEP referrals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Who Use Preventive Prophylaxis (PrEP)
Time Frame: baseline
baseline
Number of Participants Who Use Preventive Prophylaxis (PrEP)
Time Frame: At completion of the 3-month intervention (Month 3)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
At completion of the 3-month intervention (Month 3)
Number of Participants Who Use Preventive Prophylaxis (PrEP)
Time Frame: 3 months after intervention (Month 6)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
3 months after intervention (Month 6)
Number of Participants Who Use Preventive Prophylaxis (PrEP)
Time Frame: 6 months after intervention (Month 9)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
6 months after intervention (Month 9)
Number of Participants Who Use Preventive Prophylaxis (PrEP)
Time Frame: 9 months after intervention (Month 12)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
9 months after intervention (Month 12)
Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)
Time Frame: baseline
baseline
Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)
Time Frame: At completion of the 3-month intervention (Month 3)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
At completion of the 3-month intervention (Month 3)
Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)
Time Frame: 3 months after intervention (Month 6)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
3 months after intervention (Month 6)
Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)
Time Frame: 6 months after intervention (Month 9)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
6 months after intervention (Month 9)
Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)
Time Frame: 9 months after intervention (Month 12)
Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.
9 months after intervention (Month 12)
Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey
Time Frame: baseline
An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.
baseline
Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey
Time Frame: At completion of the 3-month intervention (Month 3)

An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.\

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

At completion of the 3-month intervention (Month 3)
Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey
Time Frame: 3 months after intervention (Month 6)

An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

3 months after intervention (Month 6)
Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey
Time Frame: 6 months after intervention (Month 9)

An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

6 months after intervention (Month 9)
Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey
Time Frame: 9 months after intervention (Month 12)

An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

9 months after intervention (Month 12)
Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)
Time Frame: Baseline
Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.
Baseline
Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)
Time Frame: At completion of the 3-month intervention (Month 3)

Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

At completion of the 3-month intervention (Month 3)
Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)
Time Frame: 3 months after intervention (Month 6)

Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

3 months after intervention (Month 6)
Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)
Time Frame: 6 months after intervention (Month 9)

Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

6 months after intervention (Month 9)
Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)
Time Frame: 9 months after intervention (Month 12)

Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

9 months after intervention (Month 12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental Health as Measured by the Brief Symptom Index-18
Time Frame: baseline
The Brief Symptom Inventory 18 (BSI-18) consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.
baseline
Mental Health as Measured by the Brief Symptom Index-18
Time Frame: At completion of the 3-month intervention (Month 3)
The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.
At completion of the 3-month intervention (Month 3)
Mental Health as Measured by the Brief Symptom Index-18
Time Frame: 3 months after intervention (Month 6)
The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.
3 months after intervention (Month 6)
Mental Health as Measured by the Brief Symptom Index-18
Time Frame: 6 months after intervention (Month 9)
The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.
6 months after intervention (Month 9)
Mental Health as Measured by the Brief Symptom Index-18
Time Frame: 9 months after intervention (Month 12)
The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.
9 months after intervention (Month 12)
Housing Status
Time Frame: baseline
Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.
baseline
Housing Status
Time Frame: At completion of the 3-month intervention (Month 3)
Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.
At completion of the 3-month intervention (Month 3)
Housing Status
Time Frame: 3 months after intervention (Month 6)
Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.
3 months after intervention (Month 6)
Housing Status
Time Frame: 6 months after intervention (Month 9)
Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.
6 months after intervention (Month 9)
Housing Status
Time Frame: 9 months after intervention (Month 12)
Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.
9 months after intervention (Month 12)
Number of Participants With Substance Use as Measured by Item 11 in the Texas Christian University (TCU) Drug Screen II
Time Frame: At completion of the 3-month intervention (Month 3), 3 months after intervention (Month 6), 6 months after intervention (Month 9), 9 months after intervention (Month 12)

An item from the Texas Christian University (TCU) drug screen II was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in the past 30 days. The number of participants who answered yes is reported.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

At completion of the 3-month intervention (Month 3), 3 months after intervention (Month 6), 6 months after intervention (Month 9), 9 months after intervention (Month 12)
Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)
Time Frame: baseline
The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression
baseline
Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)
Time Frame: At completion of the 3-month intervention (Month 3)

The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

At completion of the 3-month intervention (Month 3)
Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)
Time Frame: 3 months after intervention (Month 6)

The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

3 months after intervention (Month 6)
Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)
Time Frame: 6 months after intervention (Month 9)

The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

6 months after intervention (Month 9)
Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)
Time Frame: 9 months after intervention (Month 12)

The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

9 months after intervention (Month 12)
Number of Participants With Substance Use as Measured by Item 11 in the Texas Christian University (TCU) Drug Screen II
Time Frame: baseline
An item from the Texas Christian University (TCU) drug screen II was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in the past 30 days. The number of participants who answered yes is reported.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Diane Santa Maria, DrPH, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2019

Primary Completion (Actual)

April 3, 2024

Study Completion (Actual)

April 3, 2024

Study Registration Dates

First Submitted

April 8, 2019

First Submitted That Met QC Criteria

April 8, 2019

First Posted (Actual)

April 10, 2019

Study Record Updates

Last Update Posted (Actual)

June 26, 2025

Last Update Submitted That Met QC Criteria

June 6, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HSC-SN-18-0993

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior, Risk

Subscribe